[{"address1": "1 Commonwealth Lane, No. 08-22", "city": "Singapore", "zip": "149544", "country": "Singapore", "phone": "65 6250 7738", "website": "https://w2.cytomed.sg", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human cancers and degenerative diseases in Malaysia and Singapore. Its lead product candidate is CTM-N2D, an expanded gamma delta T cells grafted with natural killer group 2D ligands-targeting chimeric antigen receptor, which is in Phase I clinical trials comprising to improve anti-cancer cytotoxicity. The company is also developing iPSC-gdNKT, a pluripotent stem cell-derived gamma delta natural killer T cells platform for cancer treatment; CTM-GDT, a product candidate that consists of expanded allogeneic gamma delta T cells and exploits the potential of the cells to recognize and treat a broad range of cancers; and CTM-MSC, an injectable allogeneic umbilical cord derived mesenchymal stem cells for cartilage injury. It has research collaboration agreement with Sengkang General Hospital to provide CTM-MSC and its conditioned media for in vivo studies and Phase I clinical trial in Singapore. The company also has Business & Research Collaboration Agreement with SunAct Cancer Institute Private Limited to advance use of allogeneic off-the-shelf Gamma Delta T Cells for treatment of solid cancers. CytoMed Therapeutics Limited was incorporated in 2018 and is headquartered in Singapore.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Chee Kong  Choo", "age": 66, "title": "Executive Chairman", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 27316, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Tien Wee  Luk M.D.", "age": 38, "title": "Chief Clinical Officer", "yearBorn": 1986, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Yoong Ying  Tan", "age": 35, "title": "Chief Corporate Officer", "yearBorn": 1989, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.39, "open": 2.405, "dayLow": 2.32, "dayHigh": 2.405, "regularMarketPreviousClose": 2.39, "regularMarketOpen": 2.405, "regularMarketDayLow": 2.32, "regularMarketDayHigh": 2.405, "payoutRatio": 0.0, "forwardPE": -15.466665, "volume": 5336, "regularMarketVolume": 5336, "averageVolume": 19754, "averageVolume10days": 13320, "averageDailyVolume10Day": 13320, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 26772800, "fiftyTwoWeekLow": 1.2, "fiftyTwoWeekHigh": 4.05, "priceToSalesTrailing12Months": 23.609463, "fiftyDayAverage": 2.50604, "twoHundredDayAverage": 2.278125, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 22343572, "profitMargins": -2.21934, "floatShares": 3409857, "sharesOutstanding": 11540000, "sharesShort": 87660, "sharesShortPriorMonth": 100974, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.0076, "heldPercentInsiders": 0.70452005, "heldPercentInstitutions": 0.0013, "shortRatio": 2.78, "shortPercentOfFloat": 0.0514, "impliedSharesOutstanding": 11685500, "bookValue": 0.777, "priceToBook": 2.985843, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -2516698, "trailingEps": -0.17, "forwardEps": -0.15, "enterpriseToRevenue": 19.704, "enterpriseToEbitda": -10.25, "52WeekChange": 0.0765661, "SandP52WeekChange": 0.09765589, "quoteType": "EQUITY", "currentPrice": 2.32, "targetHighPrice": 5.0, "targetLowPrice": 5.0, "targetMeanPrice": 5.0, "targetMedianPrice": 5.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 4970367, "totalCashPerShare": 0.431, "ebitda": -2179950, "totalDebt": 463250, "quickRatio": 9.892, "currentRatio": 9.892, "totalRevenue": 1133986, "debtToEquity": 5.122, "revenuePerShare": 0.098, "returnOnAssets": -0.14013, "returnOnEquity": -0.24861, "grossProfits": 1133986, "freeCashflow": -2788594, "operatingCashflow": -2709929, "revenueGrowth": 32.986, "grossMargins": 1.0, "ebitdaMargins": -1.9223801, "operatingMargins": -0.95116997, "financialCurrency": "SGD", "symbol": "GDTC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "CytoMed Therapeutics Limited", "longName": "CytoMed Therapeutics Limited", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1681479000000, "regularMarketChange": -0.07000017, "regularMarketDayRange": "2.32 - 2.405", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 19754, "fiftyTwoWeekLowChange": 1.1199999, "fiftyTwoWeekLowChangePercent": 0.9333332, "fiftyTwoWeekRange": "1.2 - 4.05", "fiftyTwoWeekHighChange": -1.7300003, "fiftyTwoWeekHighChangePercent": -0.42716053, "fiftyTwoWeekChangePercent": 7.65661, "earningsTimestamp": 1745870400, "earningsTimestampStart": 1745870400, "earningsTimestampEnd": 1745870400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.17, "epsForward": -0.15, "epsCurrentYear": -0.17, "priceEpsCurrentYear": -13.6470585, "fiftyDayAverageChange": -0.18604016, "fiftyDayAverageChangePercent": -0.074236706, "twoHundredDayAverageChange": 0.041874886, "twoHundredDayAverageChangePercent": 0.018381294, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2023-04-14", "cryptoTradeable": false, "corporateActions": [], "regularMarketTime": 1746216000, "exchange": "NCM", "messageBoardId": "finmb_647650276", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -2.9288774, "regularMarketPrice": 2.32, "marketState": "CLOSED", "displayName": "CytoMed Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-05-03"}]